Work

RNA Interference Mediated Regulation of Tumor Cell Apoptosis

Year: 2026
Type: article
Abstract: Evasion of apoptosis is an important mechanism to resistance to anticancer therapy. This review summarizes the principles of RNA interference, tool selection, representative experimental evidence, and current progress of regulating tumor cell apoptosis. Studies have shown that silencing BCL2 can increase tumor cell apoptosis in breast cancer xenografts and enhance the anti-tumor effect of chemotherapy. Tumor cell dependence on MCL1 is influenced by compensatory activity from other anti-apoptotic proteins. The CREB3L2 and ATF5 pathways can maintain glioma cell survival through MCL1. BIRC5 silencing mainly led to impaired colony formation and abnormal mitosis, suggesting that the anti-tumor effect cannot be attributed solely to apoptosis. RNA interference identifies survival dependencies and targets for combination therapy, but its application remains limited by off-target effects, insufficient silencing, and delivery challenges. Validation using clustered regularly interspaced short palindromic repeats (CRISPR), together with studies in multiple models, is necessary to advance its therapeutic application. In particular, independent perturbations and rescue experiments can help establish whether observed phenotypes result from suppression of the intended target. Differences among tumor models also indicate that target expression alone does not establish functional dependence. Further evaluation in patient-derived models and normal cells is needed to assess both treatment sensitization and toxicity before translating these findings into therapeutic strategies.
Author: Tian Jin
Language: English
Open Access status: hybrid
OpenAlex ID: W7235474276
FWCI:
Cites: 19
Cited by:
Related to: 10